Abstract
In January 2005 the 7-valent pneumococcal conjugate vaccine (7vPCV) was funded on the National Immunisation Program for all children as a three-dose regimen given at 2, 4 and 6 months of age with a catch-up program for children up to 3 years of age. In the same year, the 23valent pneumococcal polysaccharide vaccine (23vPPV) was funded for all Australians aged 65 years and over. A 23vPPV nationally funded program for Indigenous Australians aged 50 years and over, as well as those aged 15–50 yearswith specified underlyingmedical risk factors, has been in place since 1999.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
